“More effective treatment will reduce the suffering for large patient groups and lead to health-economic benefits”


Cereno Scientific’s vision is to develop a new drug for the prevention of blood clots based on the body’s own intelligent clot-busting system.

The benefit of this new therapy compared to all current preventative antithrombotic therapy is expected to be an improved balance between blood clot prevention and side effects. This gives patients at risk for blood clots opportunities for a better preventive drug treatment. More effective treatment creates opportunities to reduce the suffering of large groups of patients leading to significant health and economic benefits.


BIO-Europe 2018 2018-11-05

Biotech and money showcase 2018 2018-11-13

Jefferies 2018 London Healthcare Conference 2018-11-14

Interim report Q3 2018-11-15

Nordic-American Life Science Conference, New York 2018-11-29

Year-end report 2018 2019-02-22

More about us...

Subscribe for corporate news

Follow us on LinkedIn

Follow us on Twitter

Privacy policy

We are proud supporters of World Thrombosis Day. Read more